Intelligence directory
Browse A–Z
Browse LongevityNext’s research articles, interventions, clinical trials and biomarker records in one alphabetical directory.
Leading punctuation is ignored. Numbers come first; accented letters and other scripts appear under Other.
Records
107 eligible records · Page 2 of 5
- Diagnostics, Canine Therapeutics and Drug Discovery: Three Different Business RisksArticle
- Digital Twins, Aging Clocks and AI Drug Discovery: Three Claims, Three Validation TestsArticle
- Disease, Wellness and Longevity Claims: The US Evidence and Scope BoundaryArticle
- DNAm GrimAge and GrimAge2Biomarker
- Do We Need Aging Clocks—or Better Answers to Specific Health Questions?Article
- DO-HEALTHTrial
- DonanemabIntervention
- ElamipretideIntervention
- Evidence-Based Longevity Clinics: A Framework for Evaluating Services, Claims, and TransparencyArticle
- Extracellular Matrix and Aging: From Tissue Mechanics to Translational EvidenceArticle
- FINGERTrial
- From 9 to 12 Hallmarks: What the Aging Framework Explains—and What It Does NotArticle
- From Preclinical Promise to Human Evidence: How to Read a Longevity Translation ClaimArticle
- Gait speedBiomarker
- Generation 100Trial
- GLP-1 Therapies and Longevity Claims: What Human Outcomes Support—and What Remains UntestedArticle
- Hearing intervention (ACHIEVE protocol)Intervention
- Icosapent ethylIntervention
- Immune Age SignalsBiomarker
- Intensive lifestyle weight-loss programme in type 2 diabetesIntervention
- Intensive systolic blood pressure controlIntervention
- JUPITER: rosuvastatin results in older participantsTrial
- LecanemabIntervention
- LIFETrial